Stem cell research promises to provide new therapies, preventive measures and even cures for some major human diseases and disorders. But some policymakers, like many Americans, have deep misgivings about the use of human embryonic tissue for this purpose. A panel talks about the therapeutic potential of stem cells, the ethical issues raised by the work, and federal funding for the research.

Guests

  • Dr. Robert Goldstein Chief scientific officer for the Juvenile Diabetes Foundation International
  • Dr. David Prentice Of Do No Harm: Coalition of Americans for Research Ethics
  • Rick Weiss Science reporter for "The Washington Post"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

The Tuskegee Study, 50 Years Later

Friday, Jul 29 2022Fifty years after the Tuskegee study, Diane talks to Harvard's Evelynn Hammonds about the intersection of race and medicine in the United States, and the lessons from history that can help us understand health inequities today.